Indeed, we found that in H460 NSCLC cells, the Dox-induced Oct-6 DNA binding activity is significantly reduced by ROS scavengers or by ATR inhibition via caffeine or shRNA silencing, but it is not affected by pifithrin-α, a pharmacological inhibitor of p53 protein. The gene discussed is POU3F1; the disease is non-small cell lung carcinoma.